Skip to main content
Log in

The moral problems with time-limited trials at the end-of-life, especially when clinicians and patients have different goals

  • Correspondence
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cheung EH-L, Cheung JC-H, Yip Y-Y (2022) Beyond failure or success: reflections on the ethical justifications for time-limited trial of intensive care. Intensive Care Med 2022:1–2. https://doi.org/10.1007/S00134-022-06752-8

    Article  Google Scholar 

  2. Donaldson TM (2021) Harming patients by provision of intensive care treatment: is it right to provide time-limited trials of intensive care to patients with a low chance of survival? Med Health Care Philos 24:227. https://doi.org/10.1007/S11019-020-09994-9

    Article  PubMed  PubMed Central  Google Scholar 

  3. Smedira NG, Evans BH, Grais LS et al (1990) Withholding and withdrawal of life support from the critically ill. N Engl J Med 322:309–315. https://doi.org/10.1056/NEJM199002013220506

    Article  CAS  PubMed  Google Scholar 

  4. Downer K, Gustin J, Lincoln T et al (2022) Communicating about time-limited trials. Chest 161:202–207. https://doi.org/10.1016/J.CHEST.2021.08.071

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas M. Donaldson.

Ethics declarations

Conflicts of interest

No competing interests or funding to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Donaldson, T.M. The moral problems with time-limited trials at the end-of-life, especially when clinicians and patients have different goals. Intensive Care Med 48, 1262–1263 (2022). https://doi.org/10.1007/s00134-022-06831-w

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-022-06831-w

Navigation